UPDATE 2-France's Ipsen to buy Merrimack's pancreatic cancer drug, assets in $1 bln deal
Jan 9 (Reuters) - French drugmaker Ipsen SA said on Monday it would buy some assets of Merrimack Pharmaceuticals Inc , including pancreatic cancer drug Onivyde, for up to $1 billion, barely a month... [Source]
Publication Date:Origin: reuters.com
Category: mergersNews
Topics: assets, cancer, pancreatic, Ipsen, month, barely, $1 billion, Onivyde, including, Pharmaceuticals, Merrimack, would, on Monday, drugmaker, French, (Reuters), Merrimack's, 2-France's, UPDATE